[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-actogenix":3,"geo-actogenix":-1,"alternatives-actogenix":22},{"id":4,"slug":5,"name":6,"wikidata_qid":7,"gleif_lei":8,"isin":8,"ultimate_parent_id":8,"hq_country_code":9,"hq_city":10,"founded_year":8,"official_website":11,"manufacturing_countries":8,"logo_url":8,"description":12,"is_eu_headquartered":13,"is_eu_manufactured":14,"eu_score_label":15,"attributes":16,"data_quality":17,"enriched_at":18,"created_at":19,"updated_at":20,"ownership_type":8,"stock_exchange":8,"tax_domicile":8,"ultimate_parent_name":8,"ultimate_parent_country":8,"data_hosting_country":8,"cloud_act_exposure":8,"ai_training_on_user_data":8,"dsa_designation":8,"gdpr_fines_total_eur":8,"gdpr_compliance_status":8,"supply_chain_transparency":8,"sustainable_materials":8,"carbon_neutral":8,"repair_recycling_program":8,"pays_eu_taxes":8,"eu_regulatory_fines":8,"b_corp_certified":8,"ethical_certifications":8,"ownership_disclosed":8,"annual_report_published":8,"supply_chain_audit_published":8,"timeline_events":8,"extended_enriched_at":8,"category_primary_id":8,"category_secondary_id":8,"category_confidence":21},"cc8650b8-8240-4b30-8ca8-0c2373acb60f","actogenix","ActoGeniX","Q4677646",null,"BE","Ghent","http:\u002F\u002Fwww.dna.com\u002F","ActoGeniX was a Belgian biopharmaceutical company based in Ghent that specialized in the development of orally active protein therapeutics. The company focused on using its ActoBiotic technology platform to engineer lactic acid bacteria for the delivery of therapeutic proteins, though it was eventually acquired by Intrexon Corporation.",true,false,"eu_hq",{"gleif_searched":13},"complete","2026-07-19T15:12:09.332+00:00","2026-07-09T06:01:15.1109+00:00","2026-07-22T16:42:36.144335+00:00",0,[]]